Injections & Infusions: Accurate Billing Procedures for Plantar Fasciitis Cortisone Injections
Plantar fasciitis is one of the most common presenting conditions in podiatry practices across the United States. While conservative treatments such as stretching, night splints, and custom orthotics form the primary line of defense, therapeutic corticosteroid injections are frequently administered to reduce localized inflammation and provide rapid pain relief. However, despite being a daily, routine procedure in most foot and ankle clinics, billing for plantar fasciitis injections is plagued by compliance traps, carrier-specific guidelines, and frequent claim rejections.
To protect your practice from costly post-payment audits and ensure clean claim submission on the first pass, podiatrists and medical billers must maintain precise alignment between clinical documentation, procedural CPT coding, HCPCS J-codes, and appropriate modifiers.
1. The Core CPT Code Selection for Plantar Fascia Injections
The most frequent coding mistake in foot care billing is confusing soft tissue injections with joint or bursa injections. When treating plantar fasciitis with a cortisone injection, the correct code to report is:
CPT 20550 (Plantar Fascia Injection): Injection(s); single tendon sheath, or ligament, aponeurosis (e.g., plantar "fascia").
It is important to note that the plantar fascia is an aponeurosis, and the CPT descriptor for 20550 names it as the example. Using joint or bursa injection codes (such as CPT 20600 or 20605 for small/intermediate joints) for a plantar fascia injection is inaccurate and represents a major audit red flag for payers.
2. Coding the Injectable Medication (HCPCS J-Codes)
In addition to coding the administration procedure (CPT 20550), practices must separately bill for the specific corticosteroid drug administered using the appropriate HCPCS Level II J-code. Commonly used steroid medications for plantar fascia injections include:
J3301, Triamcinolone Acetonide (Kenalog-10 or Kenalog-40): Injection, triamcinolone acetonide, not otherwise specified, 10 mg.
J1100, Dexamethasone Sodium Phosphate: Injection, dexamethasone sodium phosphate, 1 mg.
J0702, Betamethasone Sodium Phosphate and Betamethasone Acetate (Celestone Soluspan): Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg.
J1010, Methylprednisolone Acetate (Depo-Medrol): Injection, methylprednisolone acetate, 1 mg. Bill one unit per milligram. J1010 replaced J1020, J1030, and J1040 on April 1, 2024.
3. Billing Local Anesthetics: Can You Bill Lidocaine or Marcaine?
Podiatrists routinely mix local anesthetics (such as 1% lidocaine or 0.5% Marcaine) with the corticosteroid to provide immediate analgesia and dilute the steroid suspension. However, under standard CPT and Medicare guidelines, local anesthetics used as a diluent or for local anesthesia during a procedure are considered bundled into the primary administration fee (CPT 20550).
Do not separately bill a J-code for the anesthetic, such as HCPCS J2003 (Injection, lidocaine hydrochloride, 1 mg), when it is supplied as part of an injection procedure. Doing so will result in line-item denials or automated bundling adjustments.
4. Ultrasound Guidance: When and How to Bill CPT 76942
While many plantar fascia injections are performed using anatomical landmarks, podiatrists increasingly utilize point-of-care ultrasound (POCUS) guidance to increase injection accuracy and document pathology. When ultrasound guidance is clinically indicated and used during the injection, you may bill:
CPT 76942 (Ultrasound Guidance): Ultrasonic guidance for needle placement (e.g., biopsy, aspiration, injection, localization device), imaging supervision and interpretation.
To successfully bill CPT 76942 alongside CPT 20550, strict documentation standards must be met:
Image Retention: Permanently saved static or video images showing the needle entering the target anatomical tissue (the inflamed plantar fascia).
Documentation Requirements: A dedicated written interpretation within the clinical note describing the sonographic findings (e.g., fascia thickness greater than 4.0 mm, hypoechoic areas) and real-time needle visualization.
Medical Necessity: Documentation explaining why landmark-guided injection was insufficient (e.g., recalcitrant plantar fasciitis, prior failed injections, severe anatomical distortion).
5. Proper Use of Modifier 25 with Evaluation and Management (E/M)
One of the highest audit risks in podiatric billing occurs when billing an Evaluation and Management (E/M) office visit (CPT 99202–99215) on the same day as a plantar fascia injection (CPT 20550).
Payers assume that an established patient presenting for a scheduled injection includes pre-procedure assessment as part of the injection service. To bill a separate E/M code on the same day using Modifier 25, the clinical documentation must clearly show that a significant, separately identifiable evaluation was performed.
When Modifier 25 is Valid: An established patient presents for a follow-up on plantar fasciitis and receives an injection, but also reports a new chief complaint of an ingrown toenail on the contralateral foot. A separate history, exam, and medical decision-making are documented for the toenail.
When Modifier 25 is Invalid: A patient arrives specifically for a planned cortisone injection, and the physician notes "Foot pain severe, decision made to proceed with injection." This is considered inherent to the injection procedure and does not qualify for a separate E/M code.
6. Diagnosis Coding (ICD-10-CM) Alignment
Ensure the claim is linked to the exact ICD-10-CM diagnosis code. For plantar fasciitis, use M72.2 (Plantar fascial fibromatosis / Plantar fasciitis). Always link CPT 20550, the J-code, and CPT 76942 (if applicable) directly to M72.2 as the primary diagnosis.
Getting Injection Claims Paid the First Time
A plantar fascia injection claim pays cleanly only when the procedure code, drug code, units, modifiers, and diagnosis all match the clinical note.
At JARALL Medical Management, our certified coders review injection encounters and confirm that every code and modifier is backed by the documentation. Led by CEO Dr. Alan Bass, a DPM and Certified Professional Coder (CPC) with over 30 years of experience, our team helps you stop injection denials before they start.
Want to know how your injection claims hold up? Schedule a complimentary consultation with JARALL, and we will review your injection billing with you.